Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 9
Submit an article Journal homepage
784
Views
77
CrossRef citations to date
0
Altmetric
Original article

Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study

C. Ballard Wolfson Centre for Age-Related Diseases, King's College, London, UKCorrespondence[email protected]
,
M. Sauter Westmoreland Neurology, Greensburg, Pennsylvania, USA
,
P. Scheltens Department of Neurology, Radiology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
,
Y. He Clinical Pharmacogenetics, Novartis Pharmaceuticals Corporation, Cambridge, MA, USA
,
F. Barkhof Department of Radiology and Image Analysis Center, VU University Medical Center, Amsterdam, The Netherlands
,
E. C. W. van Straaten Department of Neurology, Radiology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
,
W. M. van der Flier Department of Neurology, Radiology and Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands
,
C. Hsu Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
,
S. Wu Novartis Pharma AG, Basel, Switzerland
&
R. Lane Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
 show all
Pages 2561-2574 | Accepted 08 Jul 2008, Published online: 30 Jul 2008

Citations (77)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Laurijn R. Draaisma, Maximilian J. Wessel & Friedhelm C. Hummel. (2020) Neurotechnologies as tools for cognitive rehabilitation in stroke patients. Expert Review of Neurotherapeutics 20:12, pages 1249-1261.
Read now
Paola Caruso, Riccardo Signori & Rita Moretti. (2019) Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit. Vascular Health and Risk Management 15, pages 259-281.
Read now

Articles from other publishers (75)

Manan Ahuja, Shailee Siddhpuria, Arian Karimi, Kaitlin Lewis, Eric Wong, Justin Lee, Christina Reppas-Rindlisbacher, Emma Sood, Christopher Gabor & Christopher Patterson. (2023) Cholinesterase inhibitors and falls, syncope and injuries in patients with cognitive impairment: a systematic review and meta-analysis. Age and Ageing 52:11.
Crossref
Guadalupe Dávila, María José Torres-Prioris, Diana López-Barroso & Marcelo L. Berthier. (2023) Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System. CNS Drugs 37:7, pages 599-637.
Crossref
Jidan Liu, Juanfen Gong, Jinchao Xu, Mengyuan Fang, Meng Su, Weiguang Li, Yiyi Wu, Yang Hui & Yingchun He. (2023) Integrated Network Pharmacology and Proteomic Analyses of Targets and Mechanisms of Jianpi Tianjing Decoction in Treating Vascular Dementia. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-18.
Crossref
Xiaoni Yang, Chao Chen, Aishuai Wang, Changsheng Li & Guangqing Cheng. (2023) Imaging, Genetic, and Pathological Features of Vascular Dementia. European Neurology 86:4, pages 277-284.
Crossref
Tran Thanh Duy Linh, Yi-Chen Hsieh, Li-Kai Huang & Chaur-Jong Hu. (2022) Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia. International Journal of Molecular Sciences 23:19, pages 11067.
Crossref
Paulo Caramelli, Valeska Marinho, Jerson Laks, Marcus Vinicius Della Coletta, Florindo Stella, Einstein Francisco Camargos, Jerusa Smid, Breno José Alencar Pires Barbosa, Lucas Porcello Schilling, Marcio Luiz Figueredo Balthazar, Norberto Anízio Ferreira Frota, Leonardo Cruz de Souza, Francisco Assis Carvalho Vale, Márcia Lorena Fagundes Chaves, Sonia Maria Dozzi Brucki, Ricardo Nitrini, Helen Bedinoto Durgante & Paulo Henrique Ferreira Bertolucci. (2022) Tratamento da demência: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Dementia & Neuropsychologia 16:3 suppl 1, pages 88-100.
Crossref
Paulo Caramelli, Valeska Marinho, Jerson Laks, Marcus Vinicius Della Coletta, Florindo Stella, Einstein Francisco Camargos, Jerusa Smid, Breno José Alencar Pires Barbosa, Lucas Porcello Schilling, Marcio Luiz Figueredo Balthazar, Norberto Anízio Ferreira Frota, Leonardo Cruz de Souza, Francisco Assis Carvalho Vale, Márcia Lorena Fagundes Chaves, Sonia Maria Dozzi Brucki, Ricardo Nitrini, Helen Bedinoto Durgante & Paulo Henrique Ferreira Bertolucci. (2022) Treatment of dementia: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Dementia & Neuropsychologia 16:3 suppl 1, pages 88-100.
Crossref
Li Li, Yawei Zheng, Jinjing Bao, Yandong Zhao, Qiuchi Zhang, Wenlei Li & Minghua Wu. (2022) Meta-Analysis of Naoxintong Capsule for Patients with Vascular Dementia. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-21.
Crossref
Xinxiu Shi, GuangHao Ren, Yang Cui & ZhongXin Xu. (2022) Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-analysis. Current Alzheimer Research 19:2, pages 133-145.
Crossref
Anand V. Patel & Richard B. Libman. 2022. Hybrid PET/MR Neuroimaging. Hybrid PET/MR Neuroimaging 441 458 .
Gerhard N. Ransmayr. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 4207 4230 .
Terence J. Quinn, Edo Richard, Yvonne Teuschl, Thomas Gattringer, Melanie Hafdi, John T. O'Brien, Niamh Merriman, Celine Gillebert, Hanne Huygelier, Ana Verdelho, Reinhold Schmidt, Emma Ghaziani, Hysse Forchammer, Sarah T. Pendlebury, Rose Bruffaerts, Milija Mijajlovic, Bogna A. Drozdowska, Emily Ball & Hugh S. Markus. (2021) European Stroke Organisation and European Academy of Neurology joint guidelines on post‐stroke cognitive impairment. European Journal of Neurology 28:12, pages 3883-3920.
Crossref
Terence J Quinn, Edo Richard, Yvonne Teuschl, Thomas Gattringer, Melanie Hafdi, John T O’Brien, Niamh Merriman, Celine Gillebert, Hanne Huyglier, Ana Verdelho, Reinhold Schmidt, Emma Ghaziani, Hysse Forchammer, Sarah T Pendlebury, Rose Bruffaerts, Milija Mijajlovic, Bogna A Drozdowska, Emily Ball & Hugh S Markus. (2021) European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. European Stroke Journal 6:3, pages I-XXXVIII.
Crossref
Emilia Salvadori, Anna Poggesi, Ida Donnini, Valentina Rinnoci, Guido Chiti, Martina Squitieri, Laura Tudisco, Fabio Fierini, Anna Melone, Francesca Pescini & Leonardo Pantoni. (2021) Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial. Drugs & Aging 38:6, pages 481-491.
Crossref
Claudia Carrarini, Mirella Russo, Fedele Dono, Filomena Barbone, Marianna G. Rispoli, Laura Ferri, Martina Di Pietro, Anna Digiovanni, Paola Ajdinaj, Rino Speranza, Alberto Granzotto, Valerio Frazzini, Astrid Thomas, Andrea Pilotto, Alessandro Padovani, Marco Onofrj, Stefano L. Sensi & Laura Bonanni. (2021) Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions. Frontiers in Neurology 12.
Crossref
Ceri E Battle, Azmil H Abdul-Rahim, Susan D Shenkin, Jonathan Hewitt & Terry J Quinn. (2021) Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:2.
Crossref
Gerhard N. Ransmayr. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 24 .
Angelika Thöne-Otto, Hermann Ackermann, Thomas Benke, Regina Bezold, Helmut Hildebrandt, Claudia Meiling, Sandra Verena Müller, Thomas Nyffeler, Karin Schoof-Tams & Claus-W. Wallesch. (2020) Kurzfassung der S2e-Leitlinie „Diagnostik und Therapie von Gedächtnisstörungen bei neurologischen Erkrankungen“ (AWMF-030/124). Zeitschrift für Neuropsychologie 31:3, pages 107-128.
Crossref
Hugh Series & Margaret Esiri. 2020. Clinical Topics in Old Age Psychiatry. Clinical Topics in Old Age Psychiatry 24 37 .
. 2020. Clinical Topics in Old Age Psychiatry. Clinical Topics in Old Age Psychiatry.
A. Yu. Emelin & V. Yu. Lobzin. (2020) Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises. Neurology, Neuropsychiatry, Psychosomatics 12:4, pages 131-136.
Crossref
Salman Al Jerdi, Rozaleen Aleyadeh & Yahia Imam. (2020) Management of Cognitive Impairment After Stroke. Current Treatment Options in Neurology 22:7.
Crossref
Sun Min Lee & So Young Moon. (2020) Clinical Reasoning: A 76-Year-Old Woman Presented with Sudden Memory Impairment. Journal of the Korean Neurological Association 38:2, pages 151-158.
Crossref
Emilia Salvadori, Anna Poggesi, Ida Donnini, Valentina Rinnoci, Guido Chiti, Martina Squitieri, Laura Tudisco, Fabio Fierini, Anna Melone, Francesca Pescini & Leonardo Pantoni. (2019) Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial. Aging Clinical and Experimental Research 32:3, pages 449-457.
Crossref
Carrie D. Patnode, Leslie A. Perdue, Rebecca C. Rossom, Megan C. Rushkin, Nadia Redmond, Rachel G. Thomas & Jennifer S. Lin. (2020) Screening for Cognitive Impairment in Older Adults. JAMA 323:8, pages 764.
Crossref
Laurijn R. Draaisma, Maximilian J. Wessel & Friedhelm C. Hummel. (2020) Non-invasive brain stimulation to enhance cognitive rehabilitation after stroke. Neuroscience Letters 719, pages 133678.
Crossref
Jie Li, Qiuhong Man, Wenchun Wang, Rizhao Pang, Jiancheng Liu, Feng Zhang & Anren Zhang. (2020) Scalp acupuncture for patients with vascular dementia. Medicine 99:43, pages e22798.
Crossref
Cindy W. Yoon. 2020. Stroke Revisited: Vascular Cognitive Impairment. Stroke Revisited: Vascular Cognitive Impairment 127 138 .
Marcelo L. Berthier, Guadalupe Dávila, Lisa Edelkraut, Diana López-Barroso, María José Torres-Prioris & Javier Tubío-Ordónez. 2020. Neurovascular Neuropsychology. Neurovascular Neuropsychology 465 500 .
Paul Noufi, Rita Khoury, Sajeeka Jeyakumar & George T. Grossberg. (2019) Use of Cholinesterase Inhibitors in Non-Alzheimer’s Dementias. Drugs & Aging 36:8, pages 719-731.
Crossref
Bomin Kim, Hee-Geun Jo, Hyung-Won Kang, Sung-Youl Choi, Min-Yeong Song, Jae-Uk Sul & Jungtae Leem. (2019) Proposal of Evidence-based East-West Integrative Medicine Manual for Vascular Dementia. Journal of Korean Medicine 40:1, pages 46-62.
Crossref
Bo-Ru Jin & Hua-Yan Liu. (2019) Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and Bayesian network meta-analysis. Neural Regeneration Research 14:5, pages 805.
Crossref
Ahmet Turan Isik, Pinar Soysal, Brendon Stubbs, Marco Solmi, Cristina Basso, Stefania Maggi, Patricia Schofield, Nicola Veronese & Christoph Mueller. (2018) Cardiovascular Outcomes of Cholinesterase Inhibitors in Individuals with Dementia: A Meta‐Analysis and Systematic Review. Journal of the American Geriatrics Society 66:9, pages 1805-1811.
Crossref
Ruth Knight, Mizanur Khondoker, Nicholas Magill, Robert Stewart & Sabine Landau. (2018) A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia. Dementia and Geriatric Cognitive Disorders 45:3-4, pages 131-151.
Crossref
Nilton Custodio, Rosa Montesinos, David Lira, Eder Herrera-Pérez, Yadira Bardales & Lucía Valeriano-Lorenzo. (2017) Mixed dementia: A review of the evidence. Dementia & Neuropsychologia 11:4, pages 364-370.
Crossref
Milija D. Mijajlović, Aleksandra Pavlović, Michael Brainin, Wolf-Dieter Heiss, Terence J. Quinn, Hege B. Ihle-Hansen, Dirk M. Hermann, Einor Ben Assayag, Edo Richard, Alexander Thiel, Efrat Kliper, Yong-Il Shin, Yun-Hee Kim, SeongHye Choi, San Jung, Yeong-Bae Lee, Osman Sinanović, Deborah A. Levine, Ilana Schlesinger, Gillian Mead, Vuk Milošević, Didier Leys, Guri Hagberg, Marie Helene Ursin, Yvonne Teuschl, Semyon Prokopenko, Elena Mozheyko, Anna Bezdenezhnykh, Karl Matz, Vuk Aleksić, DafinFior Muresanu, Amos D. Korczyn & Natan M. Bornstein. (2017) Post-stroke dementia – a comprehensive review. BMC Medicine 15:1.
Crossref
Nishila Mehta, Craig Rodrigues, Manpreet Lamba, Wei Wu, Susan E. Bronskill, Nathan Herrmann, Sudeep S. Gill, An‐Wen Chan, Robin Mason, Suzanne Day, Jerry H. Gurwitz & Paula A. Rochon. (2017) Systematic Review of Sex‐Specific Reporting of Data: Cholinesterase Inhibitor Example. Journal of the American Geriatrics Society 65:10, pages 2213-2219.
Crossref
Kyung Won Park, Eun-Joo Kim, Hyun Jeong Han, Yong S. Shim, Jae C. Kwon, Bon D. Ku, Kee Hyung Park, Hyon-Ah Yi, Kwang K. Kim, Dong Won Yang, Ho-Won Lee, Heeyoung Kang, Oh Dae Kwon, SangYun Kim, Jae-Hyeok Lee, Eun Joo Chung, Sang-Won Park, Mee Young Park, Bora Yoon, Byeong C. Kim, Sang Won Seo & Seong Hye Choi. (2017) Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial. PLOS ONE 12:8, pages e0182123.
Crossref
Eric E. Smith, Alicja Cieslak, Philip Barber, Jerry Chen, Yu‐Wei Chen, Ida Donnini, Jodi D. Edwards, Richard Frayne, Thalia S. Field, Janka Hegedus, Victoria Hanganu, Zahinoor Ismail, Jamila Kanji, Makoto Nakajima, Raza Noor, Stefano Peca, Demetrios Sahlas, Mukul Sharma, Luciano A. Sposato, Richard H. Swartz, Charlotte Zerna, Sandra E. Black & Vladimir Hachinski. (2017) Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment. Journal of the American Heart Association 6:5.
Crossref
Erin McKay & Scott E. Counts. (2017) Multi-Infarct Dementia: A Historical Perspective. Dementia and Geriatric Cognitive Disorders Extra 7:1, pages 160-171.
Crossref
Martin DichgansDidier Leys. (2017) Vascular Cognitive Impairment. Circulation Research 120:3, pages 573-591.
Crossref
Shuhua Wang, Hongling Yang, Jie Zhang, Bin Zhang, Tao Liu, Lu Gan & Jiangang Zheng. (2016) Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complementary and Alternative Medicine 16:1.
Crossref
M. Planton, J.-F. Albucher & J. Pariente. (2016) Disturbi cognitivi di origine vascolare. EMC - Neurologia 16:4, pages 1-12.
Crossref
Ayesha Khan, Raj N. Kalaria, Anne Corbett & Clive Ballard. (2016) Update on Vascular Dementia. Journal of Geriatric Psychiatry and Neurology 29:5, pages 281-301.
Crossref
Hermann AM Mucke. (2016) Drug repurposing for vascular dementia: overview and current developments. Future Neurology 11:3, pages 215-225.
Crossref
Jianping Jia, Cuibai Wei, Junhua Liang, Aihong Zhou, Xiumei Zuo, Haiqing Song, Liyong Wu, Xiaochun Chen, Shengdi Chen, Junjian Zhang, Jiang Wu, Kai Wang, Lan Chu, Dantao Peng, Peiyuan Lv, Hongzhi Guo, Xiaoyuan Niu, Yingzhu Chen, Wanli Dong, Xiujie Han, Boyan Fang, Mao Peng, Dan Li, Qian Jia & Liyuan Huang. (2015) The effects of DL‐3‐n‐butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double‐blind, placebo‐controlled trial. Alzheimer's & Dementia 12:2, pages 89-99.
Crossref
Nenad Đukić, Mihailo Nešković, Milorad Ševković & Đorđe Radak. (2016) Vascular dementia revised. Medicinska istrazivanja 50:2, pages 23-29.
Crossref
Yael D Reijmer, Susanne J van Veluw & Steven M Greenberg. (2015) Ischemic brain injury in cerebral amyloid angiopathy. Journal of Cerebral Blood Flow & Metabolism 36:1, pages 40-54.
Crossref
Andrew E. Budson & Paul R. Solomon. 2016. Memory Loss, Alzheimer's Disease, and Dementia. Memory Loss, Alzheimer's Disease, and Dementia 80 91 .
John T O'Brien & Alan Thomas. (2015) Vascular dementia. The Lancet 386:10004, pages 1698-1706.
Crossref
Meera Sheffrin, Yinghui Miao, W. John Boscardin & Michael A. Steinman. (2015) Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System. Journal of the American Geriatrics Society 63:8, pages 1512-1518.
Crossref
Aaron Ritter & Jagan A. Pillai. (2015) Treatment of Vascular Cognitive Impairment. Current Treatment Options in Neurology 17:8.
Crossref
Naveed Malek & John Greene. (2014) Cognition enhancers for the treatment of dementia. Scottish Medical Journal 60:1, pages 44-49.
Crossref
Soo-Jung HahnNam-Jong Paik. (2015) Pharmacological Treatment of Dementia. Brain & Neurorehabilitation 8:1, pages 19.
Crossref
A. Robles Bayón & F. Gude Sampedro. (2014) Inappropriate treatments for patients with cognitive decline. Neurología (English Edition) 29:9, pages 523-532.
Crossref
A. Robles Bayón & F. Gude Sampedro. (2014) Prescripciones inconvenientes en el tratamiento del paciente con deterioro cognitivo. Neurología 29:9, pages 523-532.
Crossref
Brian P. Gomoll, Brandon D. Sanders & Maria T. Caserta. (2014) Psychopharmacologic Treatments for Alzheimer Disease and Related Dementias. Psychopharm Review 49:1, pages 9-16.
Crossref
HyungSub Shim. (2013) Vascular Cognitive Impairment and Post-Stroke Cognitive Deficits. Current Neurology and Neuroscience Reports 14:1.
Crossref
Laura Silveira-Moriyama, Egberto R. Barbosa, Paulo Caramelli, Jan Zijlmans & Andrew J. Lees. 2014. Movement Disorders in Dementias. Movement Disorders in Dementias 199 211 .
Jacqueline Birks, Bernadette McGuinness & David Craig. (2013) Rivastigmine for vascular cognitive impairment. Cochrane Database of Systematic Reviews.
Crossref
Roger M. Lane & Yunsheng He. (2012) Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype. Alzheimer's & Dementia 9:2.
Crossref
Penglian Wang, Yongjun Wang, Tao Feng, Xingquan Zhao, Yong Zhou, Yilong Wang, Weixiong Shi & Yi Ju. (2012) Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE). BMC Neurology 12:1.
Crossref
Andrius Baskys & Jin-xiang Cheng. (2012) Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives. Experimental Gerontology 47:11, pages 887-891.
Crossref
John T O’BrienAlistair Burns. (2010) Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. Journal of Psychopharmacology 25:8, pages 997-1019.
Crossref
Deborah A. Levine & Kenneth M. Langa. (2011) Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications. Neurotherapeutics 8:3, pages 361-373.
Crossref
Yan Deschaintre, Fadi Massoud & Gabriel C. Léger. 2011. Case Studies in Dementia. Case Studies in Dementia 47 54 .
W. R. Brown & C. R. Thore. (2011) Review: Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathology and Applied Neurobiology 37:1, pages 56-74.
Crossref
Ae Young Lee. (2011) Vascular Dementia. Chonnam Medical Journal 47:2, pages 66.
Crossref
Andrew E. Budson & Paul R. Solomon. 2011. Memory Loss. Memory Loss 91 103 .
Dina Zekry & Gabriel Gold. (2010) Management of Mixed Dementia. Drugs & Aging 27:9, pages 715-728.
Crossref
Leonardo Pantoni. (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology 9:7, pages 689-701.
Crossref
Gustavo C. RománStephen SallowaySandra E. BlackDonald R. RoyallCharles DeCarliMichael W. WeinerMargaret MolineDinesh KumarRachel SchindlerHolly Posner. (2010) Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia. Stroke 41:6, pages 1213-1221.
Crossref
María Jesús González Moneo. (2010) Utilidad de los fármacos en la demencia. FMC - Formación Médica Continuada en Atención Primaria 17:5, pages 326-335.
Crossref
Roger M. Lane & Yunsheng He. (2009) Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE ε4, and hyperhomocysteinemia in neurodegenerative dementias. Medical Hypotheses 73:2, pages 230-250.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.